HCC
Hirtle Callaghan & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-112
| Closed | -$17K | – | 215 |
|
|
2017
Q3 | $17K | Hold |
112
| – | – | ﹤0.01% | 161 |
|
|
2017
Q2 | $14K | Sell |
112
-26
| -19% | -$3.25K | ﹤0.01% | 153 |
|
|
2017
Q1 | $16K | Hold |
138
| – | – | ﹤0.01% | 155 |
|
|
2016
Q4 | $10K | Sell |
138
-80
| -37% | -$5.8K | ﹤0.01% | 141 |
|
|
2016
Q3 | $19K | Hold |
218
| – | – | ﹤0.01% | 173 |
|
|
2016
Q2 | $19K | Sell |
218
-375
| -63% | -$32.7K | ﹤0.01% | 154 |
|
|
2016
Q1 | $46K | Sell |
593
-86
| -13% | -$6.67K | 0.01% | 135 |
|
|
2015
Q4 | $86K | Hold |
679
| – | – | 0.02% | 100 |
|
|
2015
Q3 | $70K | Hold |
679
| – | – | 0.01% | 144 |
|
|
2015
Q2 | $84K | Buy |
+679
| New | +$84K | 0.03% | 146 |
|
|
2013
Q4 | – | Sell |
-6
| Closed | – | – | 655 |
|
|
2013
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 636 |
|